Company Discovery Laboratories, Inc. Nasdaq
Equities
US2546684034
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
16/04 | Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
11/04 | North American Morning Briefing : Stock Futures -2- | DJ |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 01/16/01 |
Eric Curtis
COO | Chief Operating Officer | 56 | 09/20/09 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Steven Simonson
CTO | Chief Tech/Sci/R&D Officer | 65 | 20/14/20 |
Jamie McAndrew
AUD | Comptroller/Controller/Auditor | 44 | 01/13/01 |
Diane Carman
LAW | General Counsel | 55 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 03/21/03 |
Mark Strobeck
BRD | Director/Board Member | 53 | 22/23/22 |
Leslie Williams
BRD | Director/Board Member | 64 | 03/21/03 |
Craig Fraser
CEO | Chief Executive Officer | 59 | 01/16/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 510,178 | 486,423 ( 95.34 %) | 0 ( 0.000011 %) | 95.34 % |
Company contact information
Windtree Therapeutics, Inc.
2600 Kelly Road Suite 100
18976-3622, Warrington
+
http://www.windtreetx.comSector
1st Jan change | Capi. | |
---|---|---|
+29.03% | 48.16B | |
-0.10% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+11.48% | 25.59B | |
-22.74% | 18.96B | |
+9.06% | 12.92B | |
+30.01% | 12.03B | |
-1.51% | 11.77B |
- Stock Market
- Equities
- WINT Stock
- Stock
- Company Discovery Laboratories, Inc.